Product Recalls in New Hampshire

Product recalls affecting New Hampshire — including food, drugs, consumer products, medical devices, and vehicles distributed to New Hampshire. RecallDetector monitors distribution data from the FDA, USDA, CPSC, and NHTSA to show you which recalls are relevant to your area. 2,579 recalls have been distributed to New Hampshire in the last 12 months.

49,311 total recalls
2,579 in last 12 months

Showing 19211940 of 13,374 recalls

DrugApril 26, 2023· Akorn, Inc.

Recalled Item: Rifampin Capsules USP Recalled by Akorn, Inc. Due to CGMP Deviations: Firm...

The Issue: CGMP Deviations: Firm went out of business and could no longer continue...

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
DrugApril 26, 2023· Akorn, Inc.

Recalled Item: Ephedrine Sulfate Injection Recalled by Akorn, Inc. Due to CGMP Deviations:...

The Issue: CGMP Deviations: Firm went out of business and could no longer continue...

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
DrugApril 26, 2023· Akorn, Inc.

Recalled Item: Ropivacaine Hydrochloride Injection USP Recalled by Akorn, Inc. Due to CGMP...

The Issue: CGMP Deviations: Firm went out of business and could no longer continue...

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
DrugApril 26, 2023· Akorn, Inc.

Recalled Item: Atropine Sulfate Ophthalmic Solution Recalled by Akorn, Inc. Due to CGMP...

The Issue: CGMP Deviations: Firm went out of business and could no longer continue...

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
DrugApril 26, 2023· Akorn, Inc.

Recalled Item: AK-POLY-BAC (bacitracin Zinc and Polymyxin B Sulfate) Ophthalmic Ointment...

The Issue: CGMP Deviations: Firm went out of business and could no longer continue...

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
DrugApril 26, 2023· Akorn, Inc.

Recalled Item: Lorazepam Injection Recalled by Akorn, Inc. Due to CGMP Deviations: Firm...

The Issue: CGMP Deviations: Firm went out of business and could no longer continue...

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
DrugApril 26, 2023· Akorn, Inc.

Recalled Item: Naloxone Injection Recalled by Akorn, Inc. Due to CGMP Deviations: Firm went...

The Issue: CGMP Deviations: Firm went out of business and could no longer continue...

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
DrugApril 26, 2023· Akorn, Inc.

Recalled Item: Cromolyn Sodium Ophthalmic Solution Recalled by Akorn, Inc. Due to CGMP...

The Issue: CGMP Deviations: Firm went out of business and could no longer continue...

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
DrugApril 26, 2023· Akorn, Inc.

Recalled Item: IC-Green (indocyanine green for injection Recalled by Akorn, Inc. Due to...

The Issue: CGMP Deviations: Firm went out of business and could no longer continue...

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
DrugApril 26, 2023· Akorn, Inc.

Recalled Item: Amantadine Hydrochloride Oral Solution USP Recalled by Akorn, Inc. Due to...

The Issue: CGMP Deviations: Firm went out of business and could no longer continue...

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
DrugApril 26, 2023· Akorn, Inc.

Recalled Item: Pilocarpine Hydrochloride Ophthalmic Solution Recalled by Akorn, Inc. Due to...

The Issue: CGMP Deviations: Firm went out of business and could no longer continue...

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
DrugApril 26, 2023· Akorn, Inc.

Recalled Item: Levofloxacin Oral Solution Recalled by Akorn, Inc. Due to CGMP Deviations:...

The Issue: CGMP Deviations: Firm went out of business and could no longer continue...

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
DrugApril 26, 2023· Akorn, Inc.

Recalled Item: Dicyclomine Hydrochloride Injection USP Recalled by Akorn, Inc. Due to CGMP...

The Issue: CGMP Deviations: Firm went out of business and could no longer continue...

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
DrugApril 26, 2023· Akorn, Inc.

Recalled Item: Diuril (chlorothiazide sodium) Injection Recalled by Akorn, Inc. Due to CGMP...

The Issue: CGMP Deviations: Firm went out of business and could no longer continue...

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
DrugApril 26, 2023· Akorn, Inc.

Recalled Item: Fentanyl Citrate Injection Recalled by Akorn, Inc. Due to CGMP Deviations:...

The Issue: CGMP Deviations: Firm went out of business and could no longer continue...

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
DrugApril 26, 2023· Akorn, Inc.

Recalled Item: Prednisolone Oral Solution Recalled by Akorn, Inc. Due to CGMP Deviations:...

The Issue: CGMP Deviations: Firm went out of business and could no longer continue...

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
DrugApril 26, 2023· Akorn, Inc.

Recalled Item: Valproic Acid Oral Solution Recalled by Akorn, Inc. Due to CGMP Deviations:...

The Issue: CGMP Deviations: Firm went out of business and could no longer continue...

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
DrugApril 26, 2023· Akorn, Inc.

Recalled Item: Tobramycin Inhalation Solution USP Recalled by Akorn, Inc. Due to CGMP...

The Issue: CGMP Deviations: Firm went out of business and could no longer continue...

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
DrugApril 26, 2023· Akorn, Inc.

Recalled Item: Tobramycin Ophthalmic Solution Recalled by Akorn, Inc. Due to CGMP...

The Issue: CGMP Deviations: Firm went out of business and could no longer continue...

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
DrugApril 26, 2023· Akorn, Inc.

Recalled Item: Guaifenesin Oral Solution Recalled by Akorn, Inc. Due to CGMP Deviations:...

The Issue: CGMP Deviations: Firm went out of business and could no longer continue...

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund